siRNA tackles cancer: Immune checkpoint inhibitors and siRNA combinations.
作者信息
Coles Andrew H
机构信息
AbbVie Bioresearch Center, 100 Research Drive, Worcester, MA 01605, USA.
出版信息
Mol Ther Nucleic Acids. 2025 Jan 6;36(1):102429. doi: 10.1016/j.omtn.2024.102429. eCollection 2025 Mar 11.
Abstract
摘要
相似文献
1
siRNA tackles cancer: Immune checkpoint inhibitors and siRNA combinations.小干扰RNA对抗癌症：免疫检查点抑制剂与小干扰RNA联合疗法
Mol Ther Nucleic Acids. 2025 Jan 6;36(1):102429. doi: 10.1016/j.omtn.2024.102429. eCollection 2025 Mar 11.
2
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade.通过基于 siRNA 的基因沉默来推进癌症免疫疗法以实现免疫检查点阻断。
Adv Drug Deliv Rev. 2024 Jun;209:115306. doi: 10.1016/j.addr.2024.115306. Epub 2024 Apr 16.
3
Lipid-siRNA Conjugates Targeting High PD-L1 Expression as Potential Novel Immune Checkpoint Inhibitors.靶向高程序性死亡配体1（PD-L1）表达的脂质-小干扰RNA（siRNA）偶联物作为潜在的新型免疫检查点抑制剂
Biomolecules. 2025 Feb 15;15(2):293. doi: 10.3390/biom15020293.
4
Local CpG- siRNA treatment improves antitumor effects of immune checkpoint inhibitors.局部CpG-siRNA治疗可增强免疫检查点抑制剂的抗肿瘤效果。
Mol Ther Nucleic Acids. 2024 Oct 9;35(4):102357. doi: 10.1016/j.omtn.2024.102357. eCollection 2024 Dec 10.
5
Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint inhibition to boost anticancer immunity.阿昔替尼与程序性死亡受体配体1（PD-L1）小干扰RNA（siRNA）共递送，以实现血管正常化与免疫检查点抑制的协同作用，增强抗癌免疫力。
J Nanobiotechnology. 2025 Mar 10;23(1):194. doi: 10.1186/s12951-025-03170-y.
6
B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells.B7-H4免疫检查点蛋白影响肾癌细胞的活力和靶向治疗
Cells. 2022 Apr 25;11(9):1448. doi: 10.3390/cells11091448.
7
Non-viral siRNA delivery to T cells: Challenges and opportunities in cancer immunotherapy.非病毒 siRNA 递送至 T 细胞：癌症免疫疗法的挑战与机遇。
Biomaterials. 2022 Jul;286:121510. doi: 10.1016/j.biomaterials.2022.121510. Epub 2022 Apr 5.
8
Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches.利用 RNAi 纳米颗粒沉默免疫检查点可增强抗肿瘤免疫和治疗效果，优于抗体方法。
J Immunother Cancer. 2022 Feb;10(2). doi: 10.1136/jitc-2021-003928.
9
The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review.肠道微生物群在癌症对免疫检查点抑制剂反应中的新作用：一篇叙述性综述。
J Immunother Precis Oncol. 2021 Nov 16;5(1):13-25. doi: 10.36401/JIPO-21-10. eCollection 2022 Feb.
10
Local CpG- siRNA treatment improves antitumor effects of immune checkpoint inhibitors.局部CpG-siRNA治疗可增强免疫检查点抑制剂的抗肿瘤效果。
bioRxiv. 2023 Aug 19:2023.08.17.553571. doi: 10.1101/2023.08.17.553571.
引用本文的文献
1
Targeting tumor immune evasion: the role of PD-L1 siRNA in advancing cancer immunotherapy.靶向肿瘤免疫逃逸：PD-L1小干扰RNA在推进癌症免疫治疗中的作用
Med Oncol. 2025 Sep 13;42(11):471. doi: 10.1007/s12032-025-03025-4.
本文引用的文献
1
Local CpG- siRNA treatment improves antitumor effects of immune checkpoint inhibitors.局部CpG-siRNA治疗可增强免疫检查点抑制剂的抗肿瘤效果。
Mol Ther Nucleic Acids. 2024 Oct 9;35(4):102357. doi: 10.1016/j.omtn.2024.102357. eCollection 2024 Dec 10.
2
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade.通过基于 siRNA 的基因沉默来推进癌症免疫疗法以实现免疫检查点阻断。
Adv Drug Deliv Rev. 2024 Jun;209:115306. doi: 10.1016/j.addr.2024.115306. Epub 2024 Apr 16.
3
RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors.RNAi 介导的肿瘤相关免疫细胞中 STAT3/PD-L1 的沉默可诱导免疫治疗耐药肿瘤产生强大的抗肿瘤作用。
Mol Ther. 2024 Jun 5;32(6):1895-1916. doi: 10.1016/j.ymthe.2024.03.035. Epub 2024 Mar 27.
4
Codelivery of TGFβ and Cox2 siRNA inhibits HCC by promoting T-cell penetration into the tumor and improves response to Immune Checkpoint Inhibitors.转化生长因子β（TGFβ）与环氧化酶2（Cox2）小干扰RNA（siRNA）的共递送通过促进T细胞渗入肿瘤来抑制肝癌，并改善对免疫检查点抑制剂的反应。
NAR Cancer. 2024 Jan 9;6(1):zcad059. doi: 10.1093/narcan/zcad059. eCollection 2024 Mar.
5
A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy.小干扰 RNA（siRNA）的全面综述：癌症治疗的机制、治疗靶点和递送策略。
Int J Nanomedicine. 2023 Dec 13;18:7605-7635. doi: 10.2147/IJN.S436038. eCollection 2023.
6
RNAi modulation of placental sFLT1 for the treatment of preeclampsia.通过RNA干扰调节胎盘可溶性fms样酪氨酸激酶1治疗先兆子痫
Nat Biotechnol. 2018 Nov 19. doi: 10.1038/nbt.4297.
Zotero 插件